This action might not be possible to undo. Are you sure you want to continue?
Johnson & Johnson
Name: Neha Kaul Class: MMS ‘1’ Roll no: 9191 Div: B
Summited To: Mukul
S.no 1 2 3 4 5 6 7
Topic Introduction Our Company Our Purpose Research & Pipeline Research and Early Development Our Clinical Trials Conclusion
Page no 3 3 6 7 8 9 10
Introduction Johnson & Johnson :
Johnson and Johnson spread its roots to the world’s largest democracy, India, during the endemic post-independence turmoil of 1947. It was Mr. Patrick Whaley who set about with confidence and determination during this period of turbulence to begin the wok of establishing Johnson & Johnson in the subcontinent. Things progressed quickly and by 1948, Johnson’s Baby Powder was being manufactured by British Drug House in Prabhadevi, Bombay, and marketed by the company. Other consumer products like TEK toothbrushes, Johnson’s Baby Cream and Prickly Heat Powder followed suit. However, highly specialized products like Belladonna plasters, pharmaceuticals and Permacel Tapes were imported from the parent company. It was only ten years later that the company began to manufacture its own products.
Caring for the world, one person at a time... inspires and unites the people of Johnson & Johnson. We embrace research and science bringing innovative ideas, products and services to advance the health and well-being of people. Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world. Our Family of Companies comprises:
• • • •
The world’s premier consumer health company The world’s largest and most diverse medical devices and diagnostics company The world’s fourth-largest biologics company And the world’s seventh-largest pharmaceuticals company
We have more than 250 operating companies in 57 countries employing 115,500 people. Our worldwide headquarters is in New Brunswick, New Jersey, USA. To learn more about our companies, explore the map.
Our Credo Values The values that guide our decision making are spelled out in Our Credo. Put simply, Our Credo challenges us to put the needs and well-being of the people we serve first. Our Management Approach Johnson & Johnson is a company of enduring strength. We credit our strength and endurance to a consistent approach to managing our business, and to the character of our people. Our Citizenship As a global corporation, what we believe and what we do has an impact on the challenges and opportunities facing health care and business today. Corporate Governance Our Credo values guide the actions of people throughout the Johnson & Johnson Family of Companies. These values extend to our accounting and financial reporting responsibilities. Company Structure See how our Family of Companies is organized. Johnson & Johnson has more than 250 companies located in 57 countries around the world. Our Family of Companies is organized into several business segments comprised of franchises and therapeutic categories. Explore the map to learn more about our operating companies around the world. Consumer Health Care Our consumer health care companies bring you and your family a wide variety of products you use at home in your daily rituals, everything from caring for your hair, skin and teeth to caring for allergies.
Medical Devices & Diagnostics Our medical devices & diagnostics segment addresses some of the world’s most chronic and pervasive conditions through the convergence of technologies, products and services. Pharmaceuticals Our pharmaceutical companies discover and develop prescription medicines for some of the world’s most serious and prevalent diseases, ranging from cancer and rheumatoid arthritis, to life-threatening bacterial infections and HIV/AIDS. Our People & Diversity People and values are our greatest assets and diversity is a central part of the cultures across the Johnson & Johnson Family of Companies.
Johnson & Johnson was founded more than 120 years ago. Since then, we’ve brought the world new ideas and products that have transformed human health and well-being.
In September 1957, a new company, Johnson & Johnson India Ltd. was created and registered with twelve employees on its rolls. In the 50 years since its establishment as a modest 12-employee outfit, Johnson & Johnson Ltd. has gained a reputation for delivering highquality products at competitive prices. Our success, we believe, stems from our staunch commitment to caring for and catering to the needs of our customers and employees.
The Promise of Better Healthcare At Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD), we start each day focused on the promise that better healthcare can bring to patients around the world. By leveraging our world-class discovery and development expertise, we bring innovative, effective treatments for diabetes, cardiovascular disease, central nervous system disorders and pain to ease patients' suffering and to significantly improve their health and overall quality of life. While some medical conditions are very treatable, and even curable, for many patients, there are conditions where treatments are suboptimal or where there are a limited number of therapeutic options available to afford them relief. Yet, the wealth of information generated by modern medicine and the convergence of other fields underpinning science-based healthcare solutions is changing the face of science and medicine at an unprecedented pace, while opening a world of onceunforeseen possibilities. Within our labs, scientists are harnessing these advances and are breaking new ground in the development of tomorrow's medicines, with the aim of bringing patients greater relief through new treatment options. Many of the compounds we are developing have the potential to be first-in-class or best-in-class in their therapeutic category. As a result, our pipeline is strong and robust in all stages of development with technologically differentiated and therapeutically diverse compounds.
Research & Pipeline:
Performing innovative, quality research and development is key to our future. We have grown our investment in R&D significantly over the past five years and have attracted top researchers with a passion for treating patients. J&JPRD is a part of Johnson & Johnson, and as such, contributes to its overall pipeline. You can learn more about the Johnson & Johnson pharmaceutical pipeline here. Consistent with the company's long-standing tradition of serving patients and physicians, the entire pharmaceuticals segment is comprised of three, individually operated franchises, that focus on researching specific therapeutic categories. The CNS and Internal Medicine Franchise is comprised of a network of J&JPRD sites situated across the globe, that collaborate to focus on solving the underpinnings of psychiatric and other mental illnesses, pain management, anti-infectives, and cardiovascular and metabolic diseases. The Biotechnology, Immunology and Oncology Franchise is anchored at Centocor, focusing on discovering and developing novel treatments for autoimmune diseases and cancers. The Virology Franchise, headed by Tibotec, is developing a range of new products, including innovative options for patients afflicted with the HIV virus, and that will address the growing number and rate of Hepatitis C infections. We also and realize there is significant research possibilities outside of our own laboratories, and therefore we embrace partnerships. We have
a deep history of successful relationships with the leading biotech and pharmaceutical companies throughout the world.
Research and Early Development:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) in La Jolla, California was established to be a leading biotechnology center with the ambitious mission of converting genomic discoveries into marketable drugs. Our world-class biologists and chemists join forces to discover novel therapeutic agents that address unmet medical needs in inflammation, immunosuppression, inflammatory pain, central nervous system disorders, and metabolic diseases. Over 200 scientists comprise the Therapeutic, Enabling, and Early Development teams that drive research on campus. J&JPRD La Jolla's beautiful 307,000 square-foot research facility, completed in 2004, was custom designed to provide an open and flexible environment that fosters collaborative drug discovery. In 2005, the building received the Leadership in Energy and Environmental Design certification for New Construction (LEED®-NC certification) from the U.S. Green Building Council. Local Empowerment Our exceptional scientists are urged to maximize their individual contributions in small project-driven groups within larger interdependent and integrated scientific teams. A decentralized decision-making process gives each team the agility, freedom, and responsibility to choose its targets and set priorities. Our high regard for rigorous science is reflected in our approach to rewarding and promoting scientists for their research achievements. We offer a scientific career path that encourages scientific excellence and gives accomplished scientists the opportunity to advance their careers and to publish in first-tier scientific journals.
Stimulating Surroundings The J&JPRD La Jolla campus is located in the heart of San Diego's thriving academic and biomedical research community on Torrey Pines Mesa and is just minutes from the California coastline. San Diego County is known for its mild Mediterranean climate, varied terrain, 70 miles of pristine beaches, and world-class family attractions elements that create an exciting array of things to see and do around California's second largest city.
Our Clinical Trials:
As a world-leading healthcare company, we recognize that transparency about our clinical programs is part of our obligation to all who use or prescribe our medicines. To make well-informed assessments about our products, caregivers must have access to comprehensive and accurate information that is also balanced and timely. While our product labels remain the primary source of information for assessing the safety and effectiveness of our marketed medicines, registering and reporting the results of clinical studies provides patients and health care professionals with additional medically important information. Patients and health care providers can benefit from knowing about clinical studies that are open for enrollment and the results of studies from our marketed products. To ensure that information about our products and investigational drugs is easily accessible, we publicly register clinical studies that are open for enrollment and report the results of clinical trials on marketed medicines to the National Library of Medicine's website: http://www.clinicaltrials.gov. This site offers up-to-date information on federally and privately supported clinical trials for a wide range of diseases and conditions. For marketed medicines and investigational drugs, we will publicly register adequately designed and well-controlled clinical studies and studies related to serious and life-threatening diseases, regardless of location. We will reference the unique study number associated with the registration of the study in all subsequent publications and reports. Within 12-to-18 months after a trial has been completed, we aim to make the results of all adequately designed, and well-controlled clinical studies available in the peer-reviewed literature, or on a clinical study results web site, or by presenting the data at relevant scientific meetings.
For marketed medicines, we will publish the results of all adequately designed and wellcontrolled clinical studies regardless of outcome. In addition, we will assess the medical importance of results from all other clinical studies of marketed medicines, regardless of study design, and publish those study results that are significant and relevant to the clinical use of the medicine and/or the care and safety of patients.
Performing innovative, quality research and development is key to our future. J&JP have grown their investment in R&D significantly over the past five years and have attracted top researchers with a passion for treating patients. J&JPRD is a part of Johnson & Johnson, and as such, contributes to its overall pipeline. You can learn more about the Johnson & Johnson pharmaceutical pipeline through this project.